Gluten Guardians: FDA Extends Comment Period on Food Labels
Published Date: 3/18/2026
Notice
Summary
The FDA is giving everyone more time to share their thoughts on how gluten should be labeled and how to stop gluten from accidentally mixing into packaged foods. This affects food makers, people with celiac disease, and anyone who cares about gluten safety. Comments are now due by April 22, 2026, so get your ideas in before then!
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
Potential Business Labeling and Controls Requirement
The FDA is requesting information about a petition that asks the agency to require that gluten-containing ingredients be listed by name and that manufacturers implement cross-contact controls with gluten-containing grains. The FDA extended the comment period to April 22, 2026 to allow food makers more time to respond.
FDA Seeks Input on Gluten Labeling
The FDA asked for data and information on a citizen petition (from Celiac Journey) that requests requiring that all ingredients with gluten be listed by name and that cross-contact controls with gluten-containing grains be required. The original notice published January 22, 2026 requested comments by March 23, 2026 and the FDA extended the comment deadline to April 22, 2026.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-20063, Request for Nominations for Voting Members of Food and Drug Administration Advisory Committees
The FDA is looking for smart, qualified people to join its advisory committees and help make important decisions about food and drugs. If you have the right skills, you can apply anytime, but get your nomination in by November 30, 2026, for the best chance at current openings. This is a great chance to influence public health without any cost to you!
Previous / Next Documents
Previous: 2026-05258, Agency Information Collection Activities; Earth Mapping Resources Initiative (Earth MRI) Competitive Cooperative Agreement Program With State Geological Surveys
The U.S. Geological Survey is renewing its info collection for the Earth Mapping Resources Initiative (Earth MRI) program, which helps state geological surveys map and study Earth’s resources. This means states involved will keep sharing important data, helping the government plan better and reduce paperwork hassle. You’ve got until May 18, 2026, to share your thoughts, so don’t miss out!
Next: 2026-05260, Proposed Submission of Information Collection for OMB Review; Comment Request; Direct Express Enrollment Form
The Pension Benefit Guaranty Corporation (PBGC) wants to start collecting info to help people sign up for the Direct Express debit card. This new form will make enrollment easier and more organized. If you’re affected, you can share your thoughts by May 18, 2026—no cost or hassle expected!